| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 19, 2007
Accepted on March 25, 2008
Laboratoire de génétique moléculaire, Institut de recherches cliniques de Montréal (IRCM), Montréal QC H2W 1R7 Canada
* To whom correspondence should be addressed. E-mail: aurelio.balsalobre{at}ircm.qc.ca or jacques.drouin{at}ircm.qc.ca.
Cell-specific expression of the pituitary pro-opiomelanocortin (POMC) gene depends on the combinatorial action of a large number of DNA binding transcription factors. These include general and cell-restricted factors, as well as factors that act as effectors of signaling pathways. We have previously defined in the distal POMC promoter a composite regulatory element that contains targets for bHLH transcription factors conferring cell specificity and for NGFI-B orphan nuclear receptors that are responsive to CRH signaling and to glucocorticoid negative feedback. These factors act on neighboring regulatory elements, the EboxNeuro and NurRE, respectively. Currently, the EboxNeuro is thought to be the target of NeuroD1 during fetal development but this factor may not account for activity in the adult pituitary; it is also unknown whether the NurRE and NGFI-B-related factors are active before establishment of the hypothalamic-pituitary portal system. In order to assess the importance of these regulatory elements and their cognate transcription factors throughout pituitary organogenesis and in adult, we have assessed the activity of mutant POMC promoters in transgenic mice throughout development. These experiments indicate that the EboxNeuro and cognate bHLH factors are required throughout development and in the adult gland, beyond expression of NeuroD1. Similarly, the data reveal sustained importance of the NurRE and its cognate factors throughout pituitary development. These data contrast the sustained dependence throughout development on the same regulatory elements with the highly dynamic patterns of transcription factor expression and the modulation of their activity in response to signaling pathways.
NURSA Molecule Pages Link:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |